AA
ORTX

AlphaCentric Advisors’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

AlphaCentric Advisors’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,700
Closed -$73K – 223
2020
Q4 		$73K Buy
1,700
+1,410
+486% +$63.1K 0.03% 161
2020
Q3 		$12K Sell
290
-70
-19% -$3.62K 0.01% 155
2020
Q2 		$22K Buy
+360
New +$33K 0.01% 117

Other funds holding ORTX

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

AlphaCentric Advisors's ORTX Position: Q1 2021 in Review

AlphaCentric Advisors sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2021, closing a stake of 1,700 shares — an estimated $73K sold.

AlphaCentric Advisors first reported a position in ORTX in Q2 2020 and held it in 3 quarters. The position peaked at $73K in Q4 2020. 83 funds tracked by Wall St. Rank hold ORTX as of Q1 2021.

  • AlphaCentric Advisors reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • AlphaCentric Advisors sold 1,700 Orchard Therapeutics plc American Depositary Shares shares in Q1 2021, an estimated $73K.
  • AlphaCentric Advisors first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2020 and held it in 3 quarters.
  • AlphaCentric Advisors's Orchard Therapeutics plc American Depositary Shares position peaked at $73K in Q4 2020.
  • 83 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2021.

Based on AlphaCentric Advisors's 13F filing for Q1 2021, filed 9 Mar 2022.